Next 10 |
2024-05-09 10:51:52 ET More on Quoin Pharmaceuticals Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Call Transcript Quoin Pharmaceuticals GAAP EPS of -$2.08 Quoin stock craters 47% on public offering after rallying in prior session Seeking Alpha’s...
FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton Syndrome combination product Cash runway extended into late 2025 ASHBURN, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals...
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its first quart...
2024-03-14 12:57:03 ET Quoin Pharmaceuticals, Ltd. (QNRX) Q4 2023 Earnings Conference Call March 14, 2024, 8:30 AM ET Company Participants Gordon Dunn - Chief Financial Officer Michael Myers - Chief Executive Officer Conference Call Participants Nazibur R...
2024-03-13 16:21:32 ET More on Quoin Pharmaceuticals Quoin stock craters 47% on public offering after rallying in prior session Quoin stock soars 60% on FDA update for ichthyosis drug Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals Historical ear...
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical endpoints Eligibility age for enrollment into both studies has been lowered to fourteen...
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
2024-03-08 08:30:06 ET Ainos ( AIMD ) +147% . Psyence Biomedical ( PBM ) +104% . CERo Therapeutics ( CERO ) +47% . Gulf Island Fabrication ( GIFI ) +27% on Q4 earnings release . Recruiter.com ( RCRT ) +17% . Porch Group ( P...
ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its fourth qu...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 86.2% to $0.0836 on volume of 666,955,822 shares Airship AI Holdings Inc (AISP) rose 200.0% to $4.95 on volume of 217,603,607 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.6% to $...
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
FDA clearance to recruit teens in both on-going Netherton Syndrome clinical studies U.S. and International patent filed for novel Netherton Syndrome combination product Cash runway extended into late 2025 ASHBURN, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals...
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) (the "Company" or "Quoin"), a clinical stage specialty p...
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its first quart...